Advisory Research’s MiMedx Group MDXG Stock Holding History

Advisory Research’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-44,225	Closed	-$662K	–	459
2017 Q2	$662K	Buy	+44,225	New	+$590K	0.01%	342

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisory Research's MDXG Position: Q3 2017 in Review

Advisory Research sold out of MiMedx Group (MDXG) in Q3 2017, closing a stake of 44,225 shares — an estimated $662K sold.

Advisory Research first reported a position in MDXG in Q2 2017 and held it in 1 quarter. The position peaked at $662K in Q2 2017. 232 funds tracked by Wall St. Rank hold MDXG as of Q3 2017.

Advisory Research reported no remaining MiMedx Group position as of Q3 2017 after selling out during the quarter.
Advisory Research sold 44,225 MiMedx Group shares in Q3 2017, an estimated $662K.
Advisory Research first reported a position in MiMedx Group in Q2 2017 and held it in 1 quarter.
Advisory Research's MiMedx Group position peaked at $662K in Q2 2017.
232 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2017.

Based on Advisory Research's 13F filing for Q3 2017, filed 14 Nov 2017.